Bini, C.; Marcellusi, A.; Mennini, F. S.; Ripoli, S.; Fioravanti, L.; Paly, V. F.; Molinari, A.; Morelli, P.; Krotneva, S.; Li, S. Cost-Effectiveness of Brentuximab Vedotin Plus Chemotherapy As Frontline Treatment of Stage IV Hodgkin Lymphoma in Italy. Grhta 2024, 11, 248-257.